Volatile Anesthetics, Not Intravenous Anesthetic Propofol Bind to and Attenuate the Activation of Platelet Receptor Integrin αIIbβ3

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Yuki, Koichi ^a   Bu, Weiming ^b   Shimaoka, Motomu ^a,c   Eckenhoff, Roderic ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; INHALATION ANESTHETIC AGENT; INTEGRIN; INTEGRIN ALPHA2BETA3; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; PROPOFOL; SEVOFLURANE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CELL SURFACE; CHO CELL; CONTROLLED STUDY; DRUG BINDING SITE; LIGAND BINDING; MUTAGENESIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; THROMBOCYTE;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANIMALS; BLOOD PLATELETS; CHO CELLS; CRICETINAE; HUMANS; ISOFLURANE; METHYL ETHERS; MOLECULAR SEQUENCE DATA; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROPOFOL; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 84875757380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060415     Document Type: Article

References (52)

1. Franks NP, (2008) General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9: 370-386.
2. Ueda I, (1971) The effects of volatile general anesthetics on adenosine diphosphate-induced platelet aggregation. Anesthesiology 34: 405-408.
3. Ahn HJ, Chung SK, Dhong HJ, Kim HY, Ahn JH, et al. (2008) Comparison of surgical conditions during propofol or sevoflurane anaesthesia for endoscopic sinus surgery. Br J Anaesth 100: 50-54.
4. Blackwell KE, Ross DA, Kapur P, Calcaterra TC, (1993) Propofol for maintenance of general anesthesia: a technique to limit blood loss during endoscopic sinus surgery. Am J Otolaryngol 14: 262-266.
5. Eberhart LH, Folz BJ, Wulf H, Geldner G, (2003) Intravenous anesthesia provides optimal surgical conditions during microscopic and endoscopic sinus surgery. Laryngoscope 113: 1369-1373.
6. Law NL, Ng KF, Irwin MG, Man JS, (2001) Comparison of coagulation and blood loss during anaesthesia with inhaled isoflurane or intravenous propofol. Br J Anaesth 86: 94-98.
7. Manola M, De Luca E, Moscillo L, Mastella A, (2005) Using remifentanil and sufentanil in functional endoscopic sinus surgery to improve surgical conditions. ORL J Otorhinolaryngol Relat Spec 67: 83-86.
8. Pavlin JD, Colley PS, Weymuller EA Jr, Van Norman G, Gunn HC, et al. (1999) Propofol versus isoflurane for endoscopic sinus surgery. Am J Otolaryngol 20: 96-101.
9. Sivaci R, Yilmaz MD, Balci C, Erincler T, Unlu H, (2004) Comparison of propofol and sevoflurane anesthesia by means of blood loss during endoscopic sinus surgery. Saudi Med J 25: 1995-1998.
10. Tirelli G, Bigarini S, Russolo M, Lucangelo U, Gullo A, (2004) Total intravenous anaesthesia in endoscopic sinus-nasal surgery. Acta Otorhinolaryngol Ital 24: 137-144.
11. Wormald PJ, van Renen G, Perks J, Jones JA, Langton-Hewer CD, (2005) The effect of the total intravenous anesthesia compared with inhalational anesthesia on the surgical field during endoscopic sinus surgery. Am J Rhinol 19: 514-520.
12. Dogan IV, Ovali E, Eti Z, Yayci A, Gogus FY, (1999) The in vitro effects of isoflurane, sevoflurane, and propofol on platelet aggregation. Anesth Analg 88: 432-436.
13. Tuerkan HSA, Beyan C, Guzeldemir ME, Yalcin A, (1995) Effect of propofol on platelet aggregation. Br J Anaesth 74: S81.
14. Hirakata H, Ushikubi F, Toda H, Nakamura K, Sai S, et al. (1996) Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. Anesthesiology 85: 1447-1453.
15. Hirakata H, Ushikubi F, Narumiya S, Hatano Y, Nakamura K, et al. (1995) The effect of inhaled anesthetics on the platelet aggregation and the ligand-binding affinity of the platelet thromboxane A2 receptor. Anesth Analg 81: 114-118.
16. Nozuchi S, Mizobe T, Aoki H, Hiramatsu N, Kageyama K, et al. (2000) Sevoflurane does not inhibit human platelet aggregation induced by thrombin. Anesthesiology 92: 164-170.
17. Scarborough RM, Gretler DD, (2000) Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents. J Med Chem 43: 3453-3473.
18. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, et al. (1996) Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 88: 907-914.
19. Topol EJ, Byzova TV, Plow EF, (1999) Platelet GPIIb-IIIa blockers. Lancet 353: 227-231.
20. Leclerc JR, (2002) Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions. Crit Care Med 30: S332-340.
21. Jackson SP, (2007) The growing complexity of platelet aggregation. Blood 109: 5087-5095.
22. Pytela R, Pierschbacher MD, Ginsberg MH, Plow EF, Ruoslahti E, (1986) Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 231: 1559-1562.
23. Shimaoka M, Springer TA, (2003) Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2: 703-716.
24. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA, (2004) Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432: 59-67.
25. Springer TA, Zhu J, Xiao T, (2008) Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3. J Cell Biol 182: 791-800.
26. Raborn J, Wang W, Luo BH, (2011) Regulation of integrin alphaIIbbeta3 ligand binding and signaling by the metal ion binding sites in the beta I domain. Biochemistry 50: 2084-2091.
27. Horn NA, de Rossi L, Robitzsch T, Hecker KE, Hutschenreuter G, et al. (2001) Sevoflurane inhibits unstimulated and agonist-induced platelet antigen expression and platelet function in whole blood in vitro. Anesthesiology 95: 1220-1225.
28. Zhang H, Astrof NS, Liu JH, Wang JH, Shimaoka M, (2009) Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J 23: 2735-2740.
29. Yuki K, Astrof NS, Bracken C, Soriano SG, Shimaoka M, (2010) Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology 113: 600-609.
30. Yuki K, Astrof NS, Bracken C, Yoo R, Silkworth W, et al. (2008) The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J 22: 4109-4116.
31. Yuki K, Bu W, Xi J, Sen M, Shimaoka M, et al. (2012) Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1. FASEB J.
32. Luo BH, Springer TA, Takagi J, (2003) Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci U S A 100: 2403-2408.
33. Shattil SJ, Hoxie JA, Cunningham M, Brass LF, (1985) Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 260: 11107-11114.
34. Michelson AD, (1996) Flow cytometry: a clinical test of platelet function. Blood 87: 4925-4936.
35. Ginsberg MH, Frelinger AL, Lam SC, Forsyth J, McMillan R, et al. (1990) Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood 76: 2017-2023.
36. Zhu J, Luo BH, Xiao T, Zhang C, Nishida N, et al. (2008) Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell 32: 849-861.
37. Zhu J, Negri A, Provasi D, Filizola M, Coller BS, et al. Closed headpiece of integrin alphaIIbbeta3 and its complex with an alphaIIbbeta3-specific antagonist that does not induce opening. Blood 116: 5050-5059.
38. Eckenhoff RG, Xi J, Dailey WP, Inhalational anesthetic photolabeling. Methods Mol Biol 617: 437-443.
39. Eckenhoff RG, Xi J, Shimaoka M, Bhattacharji A, Covarrubias M, et al. Azi-isoflurane, a Photolabel Analog of the Commonly Used Inhaled General Anesthetic Isoflurane. ACS Chem Neurosci 1: 139-145.
40. Short TG, Aun CS, Tan P, Wong J, Tam YH, et al. (1994) A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients. Br J Anaesth 72: 302-306.
41. Gepts E, Sonck WA, Camu F, Vercruysse A, (1987) Pharmacokinetics of intravenously administered meptazinol during general anaesthesia in man. Eur J Anaesthesiol 4: 35-43.
42. Albanese J, Martin C, Lacarelle B, Saux P, Durand A, et al. (1990) Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology 73: 214-217.
43. Eckenhoff RG, (2001) Promiscuous ligands and attractive cavities: how do the inhaled anesthetics work? Mol Interv 1: 258-268.
44. Puzon-McLaughlin W, Kamata T, Takada Y, (2000) Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3). J Biol Chem 275: 7795-7802.
45. Boersma E, Akkerhuis KM, Theroux P, Califf RM, Topol EJ, et al. (1999) Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation 100: 2045-2048.
46. Kleiman NS, Lincoff AM, Flaker GC, Pieper KS, Wilcox RG, et al. (2000) Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. Circulation 101: 751-757.
47. Artoni A, Li J, Mitchell B, Ruan J, Takagi J, et al. (2004) Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. Proc Natl Acad Sci U S A 101: 13114-13120.
48. Pan Y, Zhang K, Qi J, Yue J, Springer TA, et al. Cation-pi interaction regulates ligand-binding affinity and signaling of integrin alpha4beta7. Proc Natl Acad Sci U S A 107: 21388-21393.
49. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM, (1989) Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58: 945-953.
50. Smith JW, Ruggeri ZM, Kunicki TJ, Cheresh DA, (1990) Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J Biol Chem 265: 12267-12271.
51. Baker EK, Tozer EC, Pfaff M, Shattil SJ, Loftus JC, et al. (1997) A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro. Proc Natl Acad Sci U S A 94: 1973-1978.
52. Xiong JP, Stehle T, Diefenbach B, Zhang R, Dunker R, et al. (2001) Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294: 339-345.